Article
Non‐invasive prenatal testing for aneuploidy: current status and future prospects
20 May 2013
Abstract excerpt
Non-invasive prenatal testing (NIPT) for aneuploidy using cell-free DNA in maternal plasma is revolutionizing prenatal screening and diagnosis. We review NIPT in the context of established screening and invasive technologies, the range of cytogenetic abnormalities detectable, cost, counseling and ethical issues. Current NIPT approaches involve whole-genome sequencing, targeted sequencing and assessment of single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
